Crinetics Pharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

43.44 -0.56 (-1.27%) USD | NASDAQ | Feb 20, 16:00

43.44 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
GT Biopharma, Inc.	--
Axsome Therapeutics, Inc.	--
Sutro Biopharma, Inc.	--
Gossamer Bio, Inc.	--